Logo image of AWH

ASPIRA WOMEN'S HEALTH INC (AWH) Stock Analyst Earnings Estimates

NASDAQ:AWH - Nasdaq - US04537Y2081 - Common Stock - Currency: USD

0.17  -0.06 (-24.78%)

After market: 0.1637 -0.01 (-3.71%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
AWH revenue by date.AWH revenue by date.
6.81M
46.45%
8.18M
20.12%
9.154M
11.91%
10.241M
11.87%
18.342M
79.10%
36.845M
100.88%
82.315M
123.41%
102.92M
25.03%
123.52M
20.02%
145.74M
17.99%
EBITDA
YoY % growth
AWH ebitda by date.AWH ebitda by date.
-32.3M
-82.38%
-32.46M
-0.50%
-18.653M
42.54%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
AWH ebit by date.AWH ebit by date.
-32.6M
-81.31%
-32.72M
-0.37%
-18.852M
42.38%
-17.768M
5.75%
-14.028M
21.05%
-7.192M
48.73%
-18.483M
-157.00%
-15.857M
14.21%
-12.928M
18.47%
-12.322M
4.69%
Operating Margin
AWH operating margin by date.AWH operating margin by date.
-478.71%-400.00%-205.94%-173.50%-76.48%-19.52%-22.45%-15.41%-10.47%-8.45%
EPS
YoY % growth
AWH eps by date.AWH eps by date.
-0.28
60.00%
-4.05
-1,346.43%
-1.79
55.80%
-1.08
39.63%
-0.58
46.73%
-0.26
54.39%
N/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.20
32.67%
-0.17
55.97%
-0.16
42.29%
-0.13
42.91%
-0.12
40.00%
Revenue
Q2Q % growth
2.879M
35.16%
3.939M
82.95%
4.04M
66.74%
4.646M
105.85%
5.252M
82.42%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-4.472M
-8.14%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.23
52.08%
-0.250.027.05%
Q2 2024
Q2Q % growth
-0.28 -0.310.039.11%
Q1 2024
Q2Q % growth
-0.39
46.58%
-0.34-0.05-16.13%
Q4 2023
Q2Q % growth
-0.30
50.00%
-0.450.1533.62%
Q3 2023
Q2Q % growth
-0.48
60.00%
-0.510.036.36%
Q2 2023
Q2Q % growth
-0.28
73.33%
-0.560.2849.59%
Q1 2023
Q2Q % growth
-0.73
39.17%
-0.760.033.63%
Q4 2022
Q2Q % growth
-0.60
-650.00%
-0.980.3839.07%
Q3 2022
Q2Q % growth
-1.20
-1,233.33%
-0.98-0.22-21.86%
Q2 2022
Q2Q % growth
-1.05
-1,650.00%
-1.060.010.99%
Q1 2022
Q2Q % growth
-1.20
-2,300.00%
-1.210.010.99%
Q4 2021
Q2Q % growth
-0.08
86.21%
-0.080.000.99%
Q3 2021
Q2Q % growth
-0.09
-125.00%
-0.07-0.02-27.30%
Q2 2021
Q2Q % growth
-0.06
-50.00%
-0.060.000.99%
Q1 2021
Q2Q % growth
-0.05
-25.00%
-0.180.1371.44%
Q4 2020
Q2Q % growth
-0.58 -0.04-0.54-1,335.64%
Q3 2020
Q2Q % growth
-0.04 -0.040.000.99%
AWH Yearly EPS VS EstimatesAWH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -2 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
2.257M
1.67%
2.794M-537K-19.22%
Q2 2024
Q2Q % growth
2.423M
-2.73%
2.626M-203K-7.73%
Q1 2024
Q2Q % growth
2.153M
-7.04%
2.59M-437K-16.87%
Q4 2023
Q2Q % growth
2.13M
-0.93%
2.571M-441K-17.15%
Q3 2023
Q2Q % growth
2.22M
7.25%
2.939M-719K-24.46%
Q2 2023
Q2Q % growth
2.491M
20.34%
2.828M-337K-11.92%
Q1 2023
Q2Q % growth
2.316M
22.54%
2.582M-266K-10.30%
Q4 2022
Q2Q % growth
2.15M
16.22%
2.271M-121K-5.33%
Q3 2022
Q2Q % growth
2.07M
23.95%
2.475M-405K-16.36%
Q2 2022
Q2Q % growth
2.07M
15.00%
2.424M-354K-14.60%
Q1 2022
Q2Q % growth
1.89M
26.00%
1.977M-87K-4.40%
Q4 2021
Q2Q % growth
1.85M
27.59%
1.862M-12K-0.64%
Q3 2021
Q2Q % growth
1.67M
34.68%
1.633M37K2.27%
Q2 2021
Q2Q % growth
1.8M
140.00%
1.682M118K7.02%
Q1 2021
Q2Q % growth
1.5M
22.95%
1.38M120K8.70%
Q4 2020
Q2Q % growth
1.45M
10.69%
1.313M137K10.43%
Q3 2020
Q2Q % growth
1.24M
-3.88%
1.138M102K8.96%
Q2 2020
Q2Q % growth
750K
-34.21%
%
Q1 2020
Q2Q % growth
1.22M
52.50%
%
AWH Yearly Revenue VS EstimatesAWH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 9.09% 0% 15.08%
Revenue0% -4.98% 0% -3.19%